Trials / Sponsors / Mohammed Milhem
Mohammed Milhem
Academic / Other · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors Solid Tumor, Locally Advanced Solid Tumor, Metastatic Tumor | Phase 1 | 2026-02-28 |
| Active Not Recruiting | Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic | Phase 1 / Phase 2 | 2022-09-19 |
| Completed | Chlorpromazine and Standard of Care in Glioblastoma Glioblastoma Multiforme | Phase 1 | 2022-01-28 |
| Completed | High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas Soft Tissue Sarcoma | Phase 1 / Phase 2 | 2019-06-27 |
| Active Not Recruiting | Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial Chondrosarcoma | Phase 1 | 2017-07-18 |
| Completed | Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma Pancreatic Ductal Adenocarcinoma, Sarcoma | Phase 1 | 2016-12-05 |
| Completed | SLM + Axitinib for Clear Cell RCC Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) | Phase 1 | 2016-01-01 |